Nuvalent (NUVL) executive Lane received 7,120 shares

Insider transactions reported

Benjamin Lane (executive at Nuvalent Inc., NUVL) reported that they received 7,120 shares, and returned to the company 29,433 shares, and disposed of 21,092 shares at $124.00 on Jul 15, 2026. After these transactions the filing shows 0 shares held directly and 0 shares held directly.

Reporting person

Lane Benjamin

Options and other derivatives

Holdings before and after

• Class A Common Stock: 21,092 to 0 direct
• Class A Common Stock - Restricted Stock Units: 29,433 to 0 direct
• Stock Option (Right to Buy): 731 to 0 direct

Footnotes from the filing

1. 1. Pursuant to the Agreement and Plan of Merger, dated June 9, 2026 (the Merger Agreement ), by and among (i) Nuvalent, Inc., a Delaware corporation (the Company ), (ii) GlaxoSmithKline LLC, a Delaware limited liability company ( Parent ), (iii) Harmony Row Acquisition Co., a Delaware corporation and wholly owned subsidiary of Parent ( Purchaser ), and (iv) solely for purposes of Section 9.14 therein, GSK plc, a public limited company organized under the laws of England and Wales ( Ultimate Parent ), Purchaser completed a tender offer (the Offer ) to purchase all outstanding shares of Class A Common Stock of the Company and Class B Common Stock of the Company. The shares of Class A Common Stock of the Company and Class B Common Stock of the Company that were tendered to Purchaser prior to the expiration time of the offer were exchanged for $124.00 per share, net to the seller in cash, without interest (the Offer Price ), subject to applicable withholding tax.
2. 2. (Continued from footnote 1) After completion of the Offer, pursuant to the terms of the Merger Agreement, Purchaser merged with and into the Company (the Merger ), with the Company surviving the Merger as a wholly owned subsidiary of Parent.
3. 3. Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock of the Company.
4. 4. Pursuant to the Merger Agreement, each restricted stock unit that was subject solely to time-based vesting (a Company RSU ) that was outstanding immediately prior to the effective time of the Merger, whether or not vested, was cancelled and converted into the right of the holder to receive an amount in cash (without interest and less applicable withholding taxes) equal to the product of (x) the total number of shares subject to (or deliverable under) such Company RSU immediately prior to the effective time of the Merger and (y) the Offer Price.
5. 5. Represents vesting of 3,120 Company PSUs (as defined below) that were granted to the Reporting Person on January 6, 2025, and 4,000 Company PSUs that were granted to the Reporting Person on January 7, 2026, and vested pursuant to the Merger Agreement.
6. 6. Pursuant to the Merger Agreement, each restricted stock unit that was subject to time- and performance-based vesting (a Company PSU ) that was outstanding immediately prior to the effective time of the Merger, whether or not vested, was cancelled and converted into the right of the holder to receive an amount in cash (without interest and less applicable withholding taxes) equal to the product of (x) the total number of shares subject to (or deliverable under) such Company PSU immediately prior to the effective time of the Merger, assuming applicable performance goals were achieved in full, and (y) the Offer Price.
7. 7. Pursuant to the Merger Agreement, each option to purchase shares of Common Stock (a Company Stock Option ) that was outstanding immediately prior to the effective time of the Merger, whether or not vested, was cancelled and converted into the right of the holder to receive an amount in cash (without interest and less applicable withholding taxes) equal to the product of (x) the total number of shares subject to such Company Stock Option immediately prior to the effective time of the Merger and (y) the excess, if any, of the Offer Price over the applicable exercise price per share under such Company Stock Option.

Transaction codes in this filing

Grant or award:

Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.

Sale back to the company:

Code D marks a disposition back to the company under an exempt plan, as opposed to a sale in the market.

FAQ